Prestige Consumer Healthcare (PBH) Receivables (2011 - 2026)

Prestige Consumer Healthcare has reported Receivables for 16 years, with the latest figure at $191.9 million in Q1 2026.

• On a quarterly basis, Receivables fell 1.22% year-over-year to $191.9 million in Q1 2026; TTM through Mar 2026 was $191.9 million, a 1.22% decrease from a year earlier, with the FY2026 full-year figure at $191.9 million, down 8.87% from the prior year.
• Receivables was $191.9 million for Q1 2026 at Prestige Consumer Healthcare, up from $190.5 million in the prior quarter.
• The five-year high for Receivables was $199.0 million in Q3 2025, with the low at $145.5 million in Q2 2022.
• Average Receivables over 5 years is $172.1 million, with a median of $168.4 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Receivables jumped 38.7% in 2022, then retreated 4.02% in 2024.
• Over 5 years, Receivables stood at $157.1 million in 2022, then increased by 10.95% to $174.3 million in 2023, then fell by 4.02% to $167.3 million in 2024, then climbed by 13.86% to $190.5 million in 2025, then gained by 0.77% to $191.9 million in 2026.
• The last three Receivables figures came in at $191.9 million (Q1 2026), $190.5 million (Q4 2025), and $199.0 million (Q3 2025), per Business Quant data.